Concerning interventions: The two component drug solution for use in the thoracic epidural catheter may be changed for an analgesically more efficient triple component, low dose drug solution containing a local anaesthetic, a lipophilic opioid and a adrenergic agonist to provide pain relief with a minimum of side effects (H. 1995 , Niemi and Breivik 2002 , Niemi and Breivik 2003 . Comparing the two methods for post-thoracotomy pain relief is more informative when each is performed according to best clinical practice. Also, the blocks should be tested with ice cubes before the patients are put under general anesthesia. Concerning clinical and participant reported measures: Total dose of analgesics administered in the TEB and PVB plus duration of infusion should be reported. Also, signs of local anesthetic systemic toxicity (LAST) should be reported, confer the risk of local anaesthetic accumulation when high doses are applied to provide PVB based pain relief (Richardson, Sabanathan et al. 1999) . Further, it could be suggested to measure concentrations of local anaesthetics, to possibly address the concerns of LAST associated with PVB. Also, the authors should describe how VAS was scored -were the patients asked to mark pain intensity on a 10 cm line? Table 1 : Too many lines make reduces the readability of the table. Table 2 : Total doses of local anaesthetic and opioid shoud be reported. Duration of infusions should be reported. Table 4 : With 6 out of 70 reported scores having 95% CI not including 0 for difference between the groups, the sentence "Similar patterns were seen from other questionnaire responses, with scores generally favouring PVB on average, although most estimates of uncertainty did not discount parity" may be rephrased to highlight the uncertainty, which is the most substantial finding. Also, the table is hard to read and may be redesigned. Concerning Qualitative interviews: In the manuscript, I do not find the data underlying this paragraph. Could there be a misunderstanding? General comment: The four research questions for pilot outcomes are answered by the authors in the discussion. I still have some comments. I am impressed by the high percentage (84% of those still alive) of participants returning questionnaire booklets at six months, and support the suggested shortening of the follow-up questionnaires. The National Survey of anaesthetists was carried out in 26 thoracic units, and received 43 responses, out of which 27, just about one anaesthetist per unit, indicated willingness to randomise for the future trial. This may prove to be a challenge for the future trial, with a substantial risk of some units not participating at all, and I do not fully share the authors' optimism when they describe the result of the National Survey as encouraging. The authors state in the discussion that they will not over-interpret their findings. Nevertheless, they report that "VAS pain scores were lower with PVB compared with TEB at six months on average, ..". More patients in the TEB group than in the PVB group had chronic pain prior to surgery, which may be commented on (Kehlet, Jensen et al. 2006) . The lack of reported total doses of drugs administered via PVB or TEB further weakens the report, including brief "safety" paragraph. The authors discuss future blinding of the participants to the analgesic technique, and conclude that they "have no reason to suspect that recipients of the randomised interventions have strong pre-conceptions with regard to the relative effectiveness of each analgesic technique". This is somewhat contradictory to their own report on patient preference for PVB as reason for non-randomisation (12%). Thus, in the future trial, attempts of blinding should be encouraged. In the present study, 60 procedures were carried out during a 12 month period, out of which 12 PVBs and 8 TEBs in the smaller contributing unit, reflecting one PVB per month and one TEB per more than six weeks. For 40% of the TEBs, difficulty in insertion was reported, emphasizing the need for experienced anaesthetists to do the procedure (possibly with the assistance of ultrasound?), and should be commented on by the authors. The future trial will take place in 20 thoracic units and include 1000 participants (one fifth of 5000) during a 30 month period. If the units are of equal size, which is rather improbable, each unit will include on the average 1.67 patients each month. With a 1:1 randomisation, each unit will on the average have less than one patient for each study arm per month. This could imply concerns of lack of continuity and need for advanced statistics addressing heterogeneity, which should be discussed in the present manuscript. Niemi, G. and H. Breivik (2002) . "Epinephrine markedly improves thoracic epidural analgesia produced by a small-dose infusion of ropivacaine, fentanyl, and epinephrine after major thoracic or abdominal surgery: a randomized, double-blinded crossover study with and without epinephrine." Anesth Analg 94(6): 1598-1605, table of contents. Niemi, G. and H. Breivik (2003) . "The minimally effective concentration of adrenaline in a low-concentration thoracic epidural analgesic infusion of bupivacaine, fentanyl and adrenaline after major surgery. A randomized, double-blind, dose-finding study." Acta Anaesthesiol Scand 47(4): 439-450. Purcell-Jones, G., C. E. Pither and D. M. Justins (1989) . "Paravertebral somatic nerve block: a clinical, radiographic, and computed tomographic study in chronic pain patients. 
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GENERAL COMMENTS
A nicely written manuscript and clearly this has achieved funding priority. I would like to see more discussion around the primary outcome measure and power calculation earlier in the manuscript if possible.
VERSION 1 -AUTHOR RESPONSE
Responses to reviewer's comments
Reviewer 1
How the authors would explain the use of VAS scale by postal questionnaire?
All patients have already completed identical questionnaires during inhospital stay with research nurse support. The follow-up questionnaires also had instructions to support patients.
No changes made.
Reviewer 2
Concerning background: PVB is also an epidural block (Purcell-Jones, Pither et al. 1989 , Karmakar, Kwok et al. 2000 , Luyet, Eichenberger et al. 2009 , Cowie, McGlade et al. 2010 , which should be mentioned and discussed, confer doses of analgesics to be applied and safety concerns in the study.
We disagree with the reviewer that PVB is also an epidural block. If the manuscript is accepted, we will work with the journal editors to provide a format that matches the inhouse style.
No changes made. TOPIC pilot study was a feasibility study to assess patient recruitment into a randomised study comparing TEB and PVB and measuring chronic pain at 6 months. As TOPIC pilot is not an effectiveness study, the dose (infusion, total dose) was not recorded, however, this data will be captured in large definitive funded study and should satisfy what the reviewer would like to see (study starting in Autumn 2018).
No changes made. The authors state in the discussion that they will not over-interpret their findings. Nevertheless, they report that "VAS pain scores were lower with PVB compared with TEB at six months on average, ..". More patients in the TEB group than in the PVB group had chronic pain prior to surgery, which may be commented on (Kehlet, Jensen et al. 2006 ).
As TOPIC pilot study does not assess clinical effectiveness, the authors believe that the sentence 'VAS pain scores were lower with PVB compared with TEB at six months on average but with high levels of uncertainty' provides a balanced view. The discussion also specifically how firm conclusions should not be drawn and results are required from a definitive study.
The lack of reported total doses of drugs administered via PVB or TEB further weakens the report, including brief "safety" paragraph. discussion of the definitive study (which will subsequently be published) is warranted.
Reviewer 3
Thank you for your comments. The structure of the manuscript is in accordance with the Journal instructions and also reporting guidance set out by CONSORT. 
VERSION 2 -AUTHOR RESPONSE
Reviewer 1 Dr Hilde M. Norum's comments
Responses Action
Concerning the abstract: This is a study of feasibility, which is important and could be clearly stated in the "objectives" paragraph of the abstract.
We have added this to the objectives in abstract.
The specific objective of this pilot study was to assess the feasibility of conducting a larger trial to determine whether PVB at thoracotomy is more effective in reducing CPTP compared to TEB.
Concerning background:
Informatively, the authors have included a sentence on spread of PVB injections. Dura extends into the paravertebral space (Boezaart, Lucas et al. 2009 ), which may be described by the authors. This would add clarity without conflicting with the authors' disagreement with my The response nicely describes in more detail how the interviews were done, but not which thematic issues were covered, and how the participants were recruited. Thus, it is still challenging for the reader to understand how the results emerged and consequently, for the reader to benefit from the discussion. Concerning the abstract:
The abstract in the manuscript (Objectives: Thoracotomy is considered one of the most painful surgical procedures. The incidence of chronic post-thoracotomy pain (CPTP) is up to 50%. Paravertebral blockade (PVB) may be superior to thoracic epidural blockade (TEB) in preventing CPTP. The specific objective of this pilot study was to assess the feasibility of conducting a larger trial to determine whether PVB at thoracotomy is more effective in reducing CPTP compared to TEB. Design: A randomised, parallel, external pilot study was conducted to assess whether a large randomised trial of TEB and PVB with CPTP as the primary outcome is feasible. Setting: Two adult thoracic centres in the UK Participants: All adult patients admitted for elective open thoracotomy. Participants were excluded if they were ASA physical status IV or V; or if there is contraindication to local anaesthetics; infection near the proposed puncture site; coagulation/thoracic spine disorders; required chest wall resection or emergency thoracic surgery or had a previous thoracotomy. Results: All patients presenting for thoracotomy were screened over a 12-month period with 194 found to be eligible. Of these, 69 (36%) were randomised (95%CI: 29%-42%). Discounting five participants who died, 54 of 64 participants (84%) returned questionnaire booklets at six months. The number of participants indicating at least a moderate level of chest pain at six months was lower with PVB but with high levels of uncertainty (RR: 0.7; 95%CI: 0.3-1.7 for worst pain; RR: 0.3; 95%CI: 0.0-2.8 for average). There were no safety concerns. Conclusions: A large multicentre RCT of PVB versus TEB is feasible as it is possible to randomise and follow up participants with high fidelity. Pain scores were lower on average with PVB compared to TEB but a much larger trial is required to confirm this reliably. ) differs from the one included online: Abstract bmjopen-2018-023679.R2 Background: Thoracotomy is considered one of the most painful surgical procedures. The incidence of chronic post-thoracotomy pain (CPTP) is up to 50%. Paravertebral blockade (PVB) may be superior to thoracic epidural blockade (TEB) in preventing CPTP. We wanted to assess whether a large randomised trial of these two peri-operative analgesic techniques with CPTP as the primary outcome is feasible. Methods: In this randomised, parallel, external pilot trial in two adult thoracic centres in the UK, patients admitted for elective thoracotomy were randomised to either TEB or PVB. The main feasibility outcomes were recruitment rate, screening rate and data completion. Participant-reported outcomes included worst and average chest pain scores on a visual analogue scale at six months post-randomisation. Results: All patients presenting for thoracotomy were screened over a 12-month period with 194 found to be eligible. Of these, 69 (36%) were randomised (95%CI: 29%-42%). Discounting five participants who died, 54 of 64 participants (84%) returned questionnaire booklets at six months. The number of participants indicating at least a moderate level of chest pain at six months was lower with PVB but with high levels of uncertainty (RR: 0.7; 95%CI: 0.3-1.7 for worst pain; RR: 0.3; 95%CI: 0.0-2.8 for average). There were no safety concerns. Conclusions: A large multicentre RCT of PVB versus TEB is feasible as it is possible to randomise and follow up participants with high fidelity. Pain scores were lower on average with PVB compared to TEB but a much larger trial is required to confirm this reliably. Given by this difference, I had to choose one of the abstracts to be able to revise the amnuscript. I have based my revision on the abstract included in the revised manucript, not the one presented online. For the original manuscript, I commented on several tables, and as I understood from the authors' response and the first revised version of the manuscript, the tables would be revised for the final version of the manuscript, which I anticipate would be the present. Therefore, I allow myself to comment on the tables in the current, second revised version of the manuscript. Please ignore my comments to the tables if I have misunderstood concerning the status of the tables. The paragraph "Participants and follow-up" and the included " Table 1 . Baseline characteristics of patients" lack a statistical comparison of the two included study groups -were the groups comparable? This should be included in the text and/ or by a pvalue in the table. Concerning " Table 2 . Anaesthetic technique summary": The explanation for superscript 1, "1 one participant received neither technique as they did not have an operation; " is a little confusing, possibly "they" culd be exchanged for "the patient"? And, again, a comparison of the results would be informative, were there differences between the groups? Concerning " Table 3 . Incidence of significant (>3 or >=4)" or severe pain(>=7) from Visual Analogue Scale Scores": The explanation for superscript 1 is confusing. Do the authors actually mean that "1 RR<0 indicate less incidence with PVB"? Or should it rather be "RR<1 indicates less incidence…". Concerning " The response nicely describes in more detail how the interviews were done, but not which thematic issues were covered, and how the participants were recruited. Thus, it is still challenging for the reader to understand how the results emerged and consequently, for the reader to benefit from the discussion.
We have added the following descriptions to our manuscript to describe how participants were recruited.
'Patient who were recruited to the trial were asked if they would be willing to be interviewed about their experiences of being in the trial. Those who consented to be interviewed were contacted by the qualitative researcher to arrange a telephone interview. The name and contact details of staff who had been involved in the trail and were willing to be interviewed were provided to the qualitative researcher and an interview was arranged.' 'The main themes for patient interviews included the acceptability of the trial; motivations for being involved in the trial; experiences of participating in the trial -for example, did patients feel well-informed about what involvement would entail; thoughts about the questionnaires used to assess levels of pain. The main themes from the staff interviews included experiences of patient identification and screening; experiences of the randomisation process; and reflections on the trial in general terms -what processes went well and were there any areas for improvement.' 2 Given by this difference, I had to choose one of the abstracts to be able to revise the amnuscript. I have based my revision on the abstract included in the revised manucript, not the one presented online.
We can confirm that the abstract online has also been updated correctly according to reviewer's comments.
3
The paragraph "Participants and follow-up" and the included " Table 1 . Baseline characteristics of patients" lack a statistical comparison of the two included study groups -were the groups comparable? This should be included in the text and/ or by a p-value in the table.
We politely disagree that it is appropriate to present results of statistical tests of baseline characteristics in a randomised trial. Because of the use of randomisation any imbalances could only have occurred by chance, so tests would not be appropriate to test 'comparability' <Ref: Altman DG, Dore CJ. Randomisation and baseline comparisons in clinical trials. Lancet. 1990; 335:149-153> . If it is editorial policy to produce results of such tests we will
